The Column Group
The Column GroupAbout
The Column Group (TCG) is a venture capital firm dedicated to creating the next generation of biotechnology companies. TCG focuses on early-stage drug discovery, investing in disease-focused companies with the potential to become leaders in their respective fields. The firm employs an edge-to-edge investment model, supporting companies from inception through exit, and emphasizes a hands-on approach to company building.
Frequently asked
What type of investor is The Column Group?
The Column Group (TCG) is a venture capital firm dedicated to creating the next generation of biotechnology companies. TCG focuses on early-stage drug discovery, investing in disease-focused companies with the potential to become leaders in their respective fields. The firm employs an edge-to-edge investment model, supporting companies from inception through exit, and emphasizes a hands-on approac…
What kind of firm is The Column Group?
The Column Group is a VC.
What is The Column Group's assets under management?
The Column Group manages approximately $4.0B in assets.
Where is The Column Group based?
The Column Group is based in San Francisco, United States.
What sectors does The Column Group focus on?
The Column Group focuses on Life Sciences, Healthcare, Biotechnology, Drug Discovery.
AUM
$4.0B
DOMAIN RATING
31
Comments
No comments yet. Be the first to share your take.
Founders (1)